FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 300:452-458 March 1, 1979 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied the clinical and pathological features of six cases of non-Hodgkin's lymphoma (diffuse undifferentiated in four cases and diffuse histiocytic in two cases) occuring in patients treated for Hodgkin's disease. All six patients had received both radiation and chemotherapy. Abdominal or gastrointestinal involvement was present in five of the six cases. None of the patients had evidence of Hodgkin's disease when the diagnosis of non-Hodgkin's lymphoma was made. Five of the six patients were among a study group of 579 patients with Hodgkin's disease, prospectively followed since diagnosis. At 10 years the actuarial risk of development of non-Hodgkin's lymphoma in this study group is 4.4 per cent (1.2 to 15.0) (per cent probability with 95 per cent confidence limits) and is similar to that of developing acute leukemia: 2.0 per cent (0.3 to 12.9). Non-Hodgkin's lymphoma is a second tumor that may occur late in the course of patients treated for Hodgkin's disease--particularly in patients who have received both radiation therapy and chemotherapy. Like acute leukemia, non-Hodgkin's lymphoma may be another cancer that represents a substantial late risk of combined-modality therapy.

This article has been cited by other articles:

• Krishnan, B., Morgan, G. J. (2007). Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy. Cancer Epidemiol. Biomarkers Prev. 16: 377-380 [Abstract] [Full Text]  
• Adu-Poku, K, Thomas, D W, Khan, M K, Holgate, C S, Smith, M E F (2005). Langerhans cell histiocytosis in sequential discordant lymphoma. J. Clin. Pathol. 58: 104-106 [Abstract] [Full Text]  
• van Leeuwen, F. E., Klokman, W. J., Veer, M. B. v.’t, Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., Aleman, B. M. P. (2000). Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood. JCO 18: 487-487 [Abstract] [Full Text]  
• Linch, D. C., Gosden, R. G., Tulandi, T., Tan, S.-L., Hancock, S. L. (2000). Hodgkin's Lymphoma: Choice of Therapy and Late Complications. ASH Education Book 2000: 205-221 [Abstract] [Full Text]  
• Aisenberg, A. C. (1999). Problems in Hodgkin's Disease Management. Blood 93: 761-779 [Full Text]  
• Krikorian, J. G., Palmer-Toy, D. E. (1997). Case 38-1997- Inflammation of the Ears, Anemia, and Fever 21 Years after Treatment for Hodgkin's Disease. NEJM 337: 1753-1760 [Full Text]  
• Multani, P. S., Grossbard, M. L. (1996). Staging Laparotomy in the Management of Hodgkin's Disease: Is it Still Necessary?. The Oncologist 1: 41-55 [Abstract] [Full Text]  
• Grossbard, M. L., Harris, N. L. (1994). Case 10-1994- A 37-Year-Old Woman with Thrombocytopenia and a Paragastric Mass after Treatment for Hodgkin's Disease. NEJM 330: 698-704 [Full Text]  
• Mauch, P. M., Ferry, J. A. (1993). Case 19-1993- A 39-Year-Old Man with Bilateral Renal Masses a Few Months after Treatment for Hodgkin's Disease, Stage IIA. NEJM 328: 1406-1414 [Full Text]  
• Coon, W. W., Dabich, L., Votaw, M. L. (1980). 'Secondary' Operative Staging of Patients With Lymphoma. Arch Surg 115: 401-404 [Abstract]